Publication | Closed Access
6-Shogaol has anti-amyloidogenic activity and ameliorates Alzheimer’s disease via CysLT1R-mediated inhibition of cathepsin B
54
Citations
20
References
2016
Year
Neurodegenerative DiseasesAlzheimer's DiseaseBiochemistryCathepsin BMedicineAnti-amyloidogenic ActivityCyslt1r-mediated InhibitionCell DeathDegenerative PathologyProtein MisfoldingNeuroprotectionPharmacologyProtective MechanismsNeuroinflammation
| Year | Citations | |
|---|---|---|
Page 1
Page 1